Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp t is known that appropriate rhythm control with antiarrhythmic drugs or radiofrequency catheter ablation (RFCA) may improve survival and is superior to the rate control strategy in patients with atrial fibrillation (AF). 1,2 RFCA of AF is an accepted, effective rhythm control strategy for maintaining sinus rhythm and is less invasive than the maze operation. 3 According to the ACC/AHA/ESC guidelines, RFCA is recommended as a second-line therapy in patients with AF that is resistant to flecainide, propafenone or sotalol. 4 However, AF frequently recurs despite the antiarrhythmic drugs 1,5 and even after RFCA. 2, 6 The rate of recurrence of non-paroxysmal AF (NPAF), including persistent or permanent AF after successful catheter ablation, is much higher than that of paroxysmal AF; 7-9 that is, commonly performed ablation techniques, such as bi-antral circumferential ablation with electrical isolation of the pulmonary veins (PV), are not sufficient for controlling NPAF. Two new technologies have been developed in order to obtain more promising clinical results after AF ablation: (1) 3-dimensional (3D) electroanatomical mapping system that guides linear ablation without a conduction gap, ensuring a bidirectional block, and (2) open irrigation tip catheter (OITC), which makes creating a transmural lesion more efficient and safer compared with conventional catheters (CONC). 10 However, OITC carries the risk of fluid overload in patients who require multiple linear ablations of long duration, because continuous saline infusion is required during such ablations. We hypothesized that using the OITC is more efficient and results in better clinical outcomes with minimal adverse events than does CONC for NPAF ablation, so the purpose of this study was to compare OITC and CONC in terms of efficiency, clinical outcome, and adverse events in patients who underwent RFCA of NPAF. 
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Methods

Study Subjects
Electrophysiological Mapping Procedure
The study protocol was approved by the Institutional Review Board of Anam Hospital of Korea University. All patients provided informed written consent. The high right atrium (RA), low RA, and coronary sinus (CS) were mapped with a decapolar catheter (Bard Electrophysiology Inc, Lowell, MA, USA) and duo-decapolar catheter (St Jude Medical Inc, Minnetonka, MN, USA) inserted via the left femoral vein. A quadripolar catheter was also placed in the superior vena cava (SVC). Intracardiac electrograms were recorded using a Prucka CardioLab™ electrophysiology system (General Electric Health Care System Inc, Milwaukee, WI, USA). Double trans-septal punctures were performed, and multiview pulmonary venograms were obtained. After trans-septal access was obtained, systemic anticoagulation was achieved with intravenous heparin to maintain an activated clotting time of 350-400 s. For electroanatomical mapping, the 3D geometry of both the LA and PV was generated using the NavX system (St Jude Medical) and then merged with the 3D spiral CT images. 11 To avoid inadvertent collateral injury, the esophagus was visualized by barium swallow and displayed on the monitor during the ablation procedure. To overcome the selection bias of this non-randomized retrospective study, we included patients who were mapped with the same 3D mapping technique, and ablated with a similar ablation method described as follows. We also excluded patients who underwent ablation with an aberrant technique, such as epicardial ablation. All patients initially underwent circumferential antral ablation with electrical PV isolation (PVI). Following antral ablation in the NPAF patients, we generated an LA roof line, a left lateral isthmus line, and a cavotricuspid isthmus (CTI) line and confirmed the bidirectional block by differential pacing. 12 Additional ablations were performed inside the CS if bidirectional block of the left lateral isthmus was not achieved by endocardial ablation alone. In selected patients who required substrate modification, anteroseptal and anterolateral lines were generated at the anterior LA. In patients with residual fibrillatory response after linear ablation, we performed complex fractionated atrial electrogram (CFAE) mapping 13 and ablated the areas of CFAE. 14 The endpoint of NPAF ablation was no immediate recurrence of AF after cardioversion during isoproterenol infusion (5-10 μg/min). In patients 
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who underwent RFCA with the OITC, furosemide (20 mg) was injected when more than 3L of saline was infused during the procedure. The patient's body weight was checked for at least 2 days after the RFCA procedure, and chest radiography and/or echocardiography were performed if there was any complaint of shortness of breath.
Biochemical Analysis of Plasma Pro-Atrial Natriuretic Peptide
We measured the pre-and 24-h post-RFCA plasma levels of pro-atrial natriuretic peptide (pro-ANP) using ELISA kits (R&D Systems, Minneapolis, MN, USA) to evaluate the degree of fluid overload-induced biochemical changes.
Post-Ablation Management and Follow-up
Warfarin was administered to all patients for at least 3 months after RFCA for a target INR of 2.0-3.0. Patients were asked to visit the outpatient clinic at 1, 3, 6, 9, and 12 months after RFCA and then every 6 months thereafter for follow-up. ECG was performed at every visit or any time the patient reported palpitations. Holter ECG (24-or 48-h) and/or event recorder was evaluated at 3, 6, and 12 months after RFCA, and then biannually. If any ECG documented an AF episode after the 3-month blanking period during follow-up, the patient was diagnosed as having clinical recurrence and antiarrhythmic medications were prescribed. Patients were also advised to call a clinician or visit the outpatient clinic if they experienced symptoms suggestive of an arrhythmia.
Statistical Analysis
Continuous variables are expressed as mean ± SD and were compared by Student's t-test. Categorical variables are presented as frequencies (%) and counts and were compared by chi-square analysis or with the Fisher exact test for small numbers, as appropriate. All tests were 2-tailed, with statistical significance set at P<0.05. Statistical tests were performed using SPSS version 15 (SPSS Inc, Chicago, IL, USA).
Results
Patients' Characteristics
The baseline characteristics of the patients are summarized in Table 1 . In patients in the OITC group, the proportions of those with chronic long-standing AF, combined atrial flutter/ tachycardia, hypertension or coronary artery disease were higher than in the CONC group. Also, the anteroposterior diameter of LA was longer in the OITC group than in the CONC group. Of the patients with NPAF, bi-antral ablation with circumferential PVI was achieved in 100% without exception. Linear ablation was performed at the CTI in 90%, Abbreviations see in Table 1 .
AF Ablation With Open Irrigation Tip Catheter
LA roof in 60%, left lateral isthmus in 59.4%, left-side septum 34%, posterior inferior LA in 5.9%, and LA anterior wall in 2%. Bidirectional block was tested after linear ablations and confirmed after CTI and roof ablation. We also performed additional ablation at the inside CS in 27%, SVC in 5%, and RA ablation in 8.9% of patients.
Procedure Duration and Related Complications
The total procedure time and fluoroscopic time were significantly shorter in the OITC group than in the CONC group ( Table 2) . Procedure-related complications developed in 7 of 233 patients (3%): hemopericardium in 4 (2 in OITC vs 2 in CONC), transient ischemic attack in 1 (CONC), ischemic stroke in 1 (CONC), and PV stenosis in 1 patient (CONC). We had 2 cases of hemopericardium during OITC ablation, occurring during left lateral isthmus ablation in 1 patient and caused by inadvertent catheter handling in the other patient. For optimal RF energy delivery, we used 20 W with a flow rate of 17-20 ml/min during posterior LA ablation in front of the esophagus and 30-35 W with 30 ml/min during ablation at the anterior border of the right-side of the antrum or septum. We also generated dense and fine ablation lesions in the patients with a huge dilated LA with low blood flow. The procedure-related complication rate was not statistically different between the OITC group (2.2%; 2/92) and CONC group (4.5%; 5/111, P=0.037).
Procedure-Related Fluid Overload Using OITC
The total amount of fluid infused to irrigate the tip of the OITC during RFCA was 3.18±0.93 L, and the average body weight increase was 1.81±1.24 kg in the morning after the procedure ( Figure 1A) . Among 92 patients who underwent RFCA using the OITC, symptomatic pulmonary edema and/or pleural effusion occurred in 3 (3. 
Discussion
In this study, we evaluated the potential adverse events of fluid overload after long-lasting OITC ablation of NPAF. We demonstrated that RFCA of NPAF using the OITC has a better clinical outcome with a shorter procedure time than when using the CONC. However, patients with a large LA and a large amount of fluid (>4 L) infused via the OITC need to be carefully monitored to prevent pulmonary edema or pleural effusion caused by fluid overload. 
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Using the OITC in AF Ablation
The OITC was developed to deliver RF energy to deep tissue and has been widely used in AF ablation. With the OITC, active cooling of the electrode-tissue interface during RF delivery prevents the temperature rising at the tip-tissue interface and reduces the rise in impedance, thereby enabling longer applications at higher power levels for larger and deeper lesion formation. [15] [16] [17] In addition, the maximal heating point is shifted down into the intramyocardial layers, which increases lesion depth and the diameter of the intramural lesion while the size of the surface lesion remains unchanged. In patients with NPAF, low electrogram voltage at the scar area is another factor obscuring the determination of efficient RF energy delivery and voltage abatement. In addition, with the remote navigation system, the power and stability of catheter contact differs from that of manual ablation, so the efficiency, safety, and optimal RF power when using the OITC remain to be studied. Another important disadvantage of the OITC is the potential to deliver a significant fluid load. As a result, pulmonary edema and pleural effusion may develop even in patients with normal left ventricular systolic function. During extensive and long-lasting RF ablation with the OITC, substantial peri-procedural fluid loading should be anticipated, especially in patients with NPAF and heart failure. Appropriate use of diuretics and body weight monitoring is highly recommended in such patients.
Study Limitations
This study had the limitations of a retrospective follow-up analysis. The patients were a highly selected group referred for rhythm control, and their number was also limited.
Conclusion
We evaluated the potential adverse events of fluid overload after long-lasting ablation of NPAF using the OITC. RFCA of NPAF using the OITC results in a shorter procedure time than when using a CONC. However, patients with a large LA and a large amount of infused fluid (>4 L) via the OITC need to be carefully monitored to prevent pulmonary edema or pleural effusion caused by fluid overload.
